These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37572568)

  • 41. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
    Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Glomerular Filtration Rates on Outcomes Following Percutaneous Left Atrial Appendage Closure.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Am J Cardiol; 2021 Apr; 145():77-84. PubMed ID: 33508268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure.
    Qamar SR; Jalal S; Nicolaou S; Tsang M; Gilhofer T; Saw J
    EuroIntervention; 2019 Oct; 15(8):663-670. PubMed ID: 31217149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study.
    Galea R; Mahmoudi K; Gräni C; Elhadad S; Huber AT; Heg D; Siontis GCM; Brugger N; Sebag F; Windecker S; Valgimigli M; Landolff Q; Roten L; Amabile N; Räber L
    Europace; 2022 Oct; 24(9):1441-1450. PubMed ID: 35253840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical relevance of incomplete device endothelialization after left atrial appendage closure.
    Xu J; Chen CZ; Xing J; Wang L; Tao YR; Yang B; Zhang Q; Shen YL; Hu JQ
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):451-459. PubMed ID: 36136204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcatheter embolic coils to treat peridevice leaks after left atrial appendage closure.
    Musikantow DR; Shivamurthy P; Croft LB; Kawamura I; Turagam MK; Whang W; Dukkipati SR; Goldman ME; Reddy VY
    Heart Rhythm; 2021 May; 18(5):717-722. PubMed ID: 33549807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices.
    Mansour MJ; Harnay E; Al Ayouby A; Mansourati V; Jobic Y; Gilard M; Le Ven F; Mansourati J
    J Interv Card Electrophysiol; 2022 Jun; 64(1):27-34. PubMed ID: 34002319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
    Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the WATCHMAN left atrial appendage closure device.
    Alli O; Holmes D
    Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Left Atrial Appendage Closure on LAA Thrombus Formation and Thromboembolism After LAA Isolation.
    Fink T; Vogler J; Heeger CH; Sano M; Sciacca V; Reissmann B; Wohlmuth P; Keelani A; Schütte C; Eitel C; Eitel I; Maurer T; Rottner L; Rillig A; Mathew S; Metzner A; Ouyang F; Kuck KH; Tilz RR
    JACC Clin Electrophysiol; 2020 Dec; 6(13):1687-1697. PubMed ID: 33334448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial.
    Doshi SK; Kar S; Sadhu A; Horton R; Osorio J; Ellis C; Stone J; Shah M; Dukkipati SR; Adler S; Nair DG; Kim J; Wazni O; Price MJ; Holmes DR; Shipley R; Christen T; Allocco DJ; Reddy VY;
    J Am Heart Assoc; 2023 Feb; 12(4):e026295. PubMed ID: 36789852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders.
    Lakkireddy D; Nielsen-Kudsk JE; Windecker S; Thaler D; Price MJ; Gambhir A; Gupta N; Koulogiannis K; Marcoff L; Mediratta A; Anderson JA; Gage R; Ellis CR
    Europace; 2023 Aug; 25(9):. PubMed ID: 37584233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure.
    Zhang Z; Zhou J; Lin Q; Wang C; Huang Y; Dai Y; Zuo W; Liu N; Xiao Y; Liu Q
    BMC Cardiovasc Disord; 2024 Mar; 24(1):175. PubMed ID: 38515032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex Differences in the Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis.
    Abusnina W; Latif A; Al-Abdouh A; Mostafa MR; Radaideh Q; Alshebani Y; Aboeata A; Ben-Dor I; Michos ED; Dahal K
    Cardiovasc Revasc Med; 2022 Aug; 41():29-34. PubMed ID: 34952822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left Atrial Appendage Closure with Watchman vs Amulet Devices: Similarities and Differences.
    Ahmed A; Bawa D; Kabra R; Pothineni NVK; Darden D; Gopinathannair R; Lakkireddy D
    Curr Cardiol Rep; 2023 Sep; 25(9):909-915. PubMed ID: 37584874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
    Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
    Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
    Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D;
    Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation.
    Wei Z; Zhang X; Wu H; Xie J; Dai Q; Wang L; Xu B
    Medicine (Baltimore); 2016 Aug; 95(31):e4382. PubMed ID: 27495048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort.
    Schrag M; Mac Grory B; Nackenoff A; Eaton J; Mistry E; Kirshner H; Yaghi S; Ellis CR
    Transl Stroke Res; 2021 Apr; 12(2):259-265. PubMed ID: 32770310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stroke prevention of thoracoscopic left atrial appendage clipping in patients with non-valvular atrial fibrillation at high risk of stroke and bleeding: study protocol for a non-randomised controlled clinical trial.
    Ye C; Han X; Chen Y; Liu F; Ma H; Yang Y; Liu Y; Hu Q; Yao Q; Xie W; Xu D
    BMJ Open; 2022 Oct; 12(10):e063931. PubMed ID: 36307161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.